The Pharmaceutical Congress Asia recognizes the importance of navigating through the complexities of Asia’s unique healthcare environments, regulation, clinical research capabilities and operational efficiencies to successfully bring pharmaceutical products and services to the market.
Packed with case studies from market leaders, three agendas will unite to create a hub of research, innovation, improved regulatory frameworks, best practice business, marketing and distribution models that will define Asia’s pharmaceutical future.
Head of Scientific Office, Austrian Agency for Health and Food Safety (AGES), PharmMed & Member, Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMA), Austria
Regional Market Access Lead –Asia Pacific, Janssen, Singapore
Global Regulatory Affairs & Policy, Biopharmaceuticals, Amgen Inc, US
Senior Advisor- Market Access & Health Policy, Bayer Yakuhin Ltd, Japan
Dr Viraj Rajadhyaksha
Medical Director, AstraZeneca, Singapore
Prof. Yitzhak Peterburg
Chairman of the Board of Directors, Teva Pharmaceutical Industries
Senior Vice President, Global Clinical Operations, Merck
Senior Director of Clinical development, Asia development Dept., Daiichi Sankyo Co Ltd
Vice President, Global Clinical Development, Group Head Cardiovascular Risk Management and Women’s Health, Bayer Healthcare
©2016, an Informa business